aspirin has been researched along with Anemia, Cooley's in 11 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The strict adherence to aspirin and dipyridamole has led to no stroke or progression of the vasculopathy for 8 years." | 3.73 | Moyamoya syndrome in a splenectomized patient with beta-thalassemia intermedia. ( Hara, T; Kira, R; Ohga, S; Sanefuji, M; Torisu, H; Yoshiura, T, 2006) |
| "An incidence as high as 60% of silent cerebral infarcts (SCI) has been demonstrated by brain Magnetic Resonance Imaging (MRI) studies in beta thalassemia intermedia (TI)." | 1.43 | High incidence of silent cerebral infarcts in adult patients with beta thalassemia major. ( Cohen, M; Inbar, E; Pazgal, I; Shpilberg, O; Stark, P, 2016) |
| "Deferoxamine therapy was continued throughout 2 pregnancies, while in the other it was stopped after 8 weeks: no abnormalities were noted in the children." | 1.31 | High-risk pregnancy in beta-thalassemia major women. Report of three cases. ( De Marzi, CA; Magliari, F; Perniola, R; Rosatelli, MC, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Solomou, EE | 1 |
| Delaporta, P | 1 |
| Mantzou, A | 1 |
| Tzannoudaki, M | 1 |
| Diamantopoulos, P | 1 |
| Salamaliki, C | 1 |
| Kontandreopoulou, CN | 1 |
| Vyniou, NA | 1 |
| Perganti, F | 1 |
| Papassotiriou, I | 1 |
| Kattamis, A | 1 |
| Bahrani, S | 1 |
| Teimouri-Jervekani, Z | 1 |
| Sadeghi, M | 1 |
| Karimi, M | 1 |
| Haghpanah, S | 1 |
| Pishdad, P | 1 |
| Zahedi, Z | 1 |
| Parand, S | 1 |
| Safaei, S | 1 |
| Pazgal, I | 1 |
| Inbar, E | 1 |
| Cohen, M | 1 |
| Shpilberg, O | 1 |
| Stark, P | 1 |
| Roumi, JE | 1 |
| Moukhadder, HM | 1 |
| Graziadei, G | 1 |
| Pennisi, M | 1 |
| Cappellini, MD | 1 |
| Taher, AT | 1 |
| Mannucci, PM | 1 |
| Kahn, JE | 1 |
| Veyssier-Belot, C | 1 |
| Renier, JL | 1 |
| de Mazancourt, P | 1 |
| Peltier, JY | 1 |
| de Raucourt, E | 1 |
| Engelborghs, S | 1 |
| Pickut, BA | 1 |
| De Deyn, PP | 1 |
| Sanefuji, M | 1 |
| Ohga, S | 1 |
| Kira, R | 1 |
| Yoshiura, T | 1 |
| Torisu, H | 1 |
| Hara, T | 1 |
| Eber, S | 1 |
| Perniola, R | 1 |
| Magliari, F | 1 |
| Rosatelli, MC | 1 |
| De Marzi, CA | 1 |
1 review available for aspirin and Anemia, Cooley's
| Article | Year |
|---|---|
Thrombotic Events and Anticoagulants in Beta-thalassemia Patients with Focus on Anticoagulants for Atrial Fibrillation: A Brief Review.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; beta-Thalassemia; Hemorrhage; Hu | 2022 |
1 trial available for aspirin and Anemia, Cooley's
| Article | Year |
|---|---|
Frequency of silent brain lesions and aspirin protection evaluation over 3 years follow-up in beta thalassemia patients.
Topics: Adolescent; Adult; Aspirin; beta-Thalassemia; Child; Female; Follow-Up Studies; Humans; Magnetic Res | 2019 |
9 other studies available for aspirin and Anemia, Cooley's
| Article | Year |
|---|---|
Evidence that platelets from transfusion-dependent β-thalassemia patients induce T cell activation.
Topics: Aspirin; beta-Thalassemia; Blood Platelets; Humans; Platelet Activation; Thrombosis | 2023 |
High incidence of silent cerebral infarcts in adult patients with beta thalassemia major.
Topics: Adult; Aspirin; beta-Thalassemia; Cerebral Infarction; Cerebrum; Female; Ferritins; Fibrinolytic Age | 2016 |
Pregnancy in β-thalassemia intermedia at two tertiary care centers in Lebanon and Italy: A follow-up report on fetal and maternal outcomes.
Topics: Abortion, Habitual; Abortion, Spontaneous; Aspirin; beta-Thalassemia; Birth Weight; Cesarean Section | 2017 |
Red cells playing as activated platelets in thalassemia intermedia.
Topics: Aspirin; beta-Thalassemia; Blood Platelets; Erythrocytes; Hematology; Hemoglobins; Humans; Hydroxyur | 2010 |
Recurrent thromboembolism in a patient with beta-thalassemia major associated with double heterozygosity for factor V R506Q and prothrombin G20210A mutations.
Topics: 3' Untranslated Regions; Activated Protein C Resistance; Adult; Anticoagulants; Aspirin; beta-Thalas | 2002 |
Recurrent transient ischemic attacks in a 15-year-old boy with beta-thalassemia minor and thrombophilia. Contribution of perfusion SPECT to clinical diagnosis.
Topics: Adolescent; Anticoagulants; Aspirin; beta-Thalassemia; Brain; Factor V; Female; Heterozygote; Humans | 2003 |
Moyamoya syndrome in a splenectomized patient with beta-thalassemia intermedia.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; beta-Thalassemia; Carotid Arteries; Di | 2006 |
[Thalassemia minor. Drug intolerance and psychiatric manifestations].
Topics: Aspirin; beta-Thalassemia; Combined Modality Therapy; Humans; Neurocognitive Disorders; Platelet Agg | 1998 |
High-risk pregnancy in beta-thalassemia major women. Report of three cases.
Topics: Adult; Aspirin; beta-Thalassemia; Cardiomyopathy, Dilated; Deferoxamine; Female; Humans; Pregnancy; | 2000 |